400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / Transferase / ABT-100
CAS No.: 450839-40-4
Synonyms: A-367074
ABT-100 is an orally bioavailable farnesyltransferase inhibitor. ABT-100 inhibited proliferation of cells in vitro carrying oncogenic H-Ras (EJ-1 bladder; IC(50) 2.2 nmol/L), Ki-Ras (DLD-1 colon, MDA-MB-231 breast, HCT-116 colon, and MiaPaCa-2 pancreatic; IC(50) range, 3.8-9.2 nmol/L), and wild-type Ras (PC-3 and DU-145; IC(50), 70 and 818 nmol/L, respectively) as well as clonogenic potential. ABT-100 shows 70% to 80% oral bioavailability in mice. ABT-100 regressed EJ-1 tumors (2-12.5 mg/kg/d s.c., every day for 21 days) and showed significant efficacy in DLD-1, LX-1, MiaPaCa-2, or PC-3 tumor-bearing mice (6.25-50 mg/kg/d s.c. once daily or twice daily orally).
生物活性
实验方案
技术信息
CAS号 | 450839-40-4 | 储存条件 |
|
|
分子式 | C27H19F3N4O3 | 运输 | 蓝冰 | |
分子量 | 504.46 | 别名 | A-367074 |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网